Open access
89
Views
3
CrossRef citations to date
0
Altmetric
Review
Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
Clemens Warnke1 Department of Neurology, Heinrich-Heine University Düsseldorf, Germany
, Heinz Wiendl2 Department of Neurology – Inflammatory Disorders of the Nervous System and Neurooncology, University of Münster, Germany
, Hans-Peter Hartung1 Department of Neurology, Heinrich-Heine University Düsseldorf, Germany
, Olaf Stüve3 Department of Neurology, Dallas VA Medical Center and UT Southwestern Medical Center, Dallas, Texas, USA
& Bernd C Kieseier1 Department of Neurology, Heinrich-Heine University Düsseldorf, GermanyCorrespondence[email protected]
Pages 117-126
|
Published online: 18 Jun 2010
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.